December 2009
Multiple myeloma is an aggressive, incurable blood disease with poor survival rates and approximately 20,000 cases per year in the United States. While therapeutic improvements have been made in the last decade, the disease remains incurable and the patients eventually succumb after failing currently available treatments.
CRI postdoctoral fellow Dr. Diego Acosta-Alvear is working to discover new therapeutic targets in multiple myeloma. To accomplish this, he is studying the unfolded protein response (UPR), a critical cellular mechanism involved in cell growth, communication, and survival.
Click on the image above to view a video interview with Diego.
Diego is one of 98 CRI-funded postdoctoral fellows currently bringing new ideas, energy, and creativity to the world's top laboratories to solve the cancer problem. Their discoveries provide the foundation for tomorrow's life-saving therapies.
Please make a gift today to support the work of young scientists like Diego. Your support helps to keep talent like his focused on finding new and better ways to treat, control, and prevent cancer.
|